Shandong NHU Amino Acids Co., Ltd. announced that it will receive CNY 1,000,000,000 in an equity round of funding on August 22, 2022. The transaction will include participation from existing investor Zhejiang NHU Company Ltd. The investor will continue to retain 100% stake in the transaction. Out of the total funding, CNY 100,000,000 will go to registered capital and CNY 900,000,000 will go to capital reserve.

The transaction has been approved at the 12th meeting of the 8th board of directors and the 10th meeting of the 8th board of supervisors of the investor.